Christine Shaw serves as Executive at GenMark Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Christine Shaw has executed 13 insider transactions totaling $85.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 22, 2021 involved transacting 101,324 shares valued at $2.4M.
Christine Shaw currently holds 100,466 shares of GenMark Diagnostics, Inc. (GNMK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Shaw has been a net seller of GNMK stock. They have purchased $0 and sold $85.8K worth of shares.
Christine Shaw's most recent insider trade was on Apr 22, 2021, when they sold 101,324 shares at $24.05 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 5, 2021 | GNMK | $5.1K | Sale | 274 | $18.56 | Discretionary |
| Feb 26, 2021 | GNMK | $53.7K | Sale | 3,151 | $17.03 | Discretionary |
| Feb 24, 2021 | GNMK | $5.0K | Sale | 259 | $19.12 | Discretionary |
| Feb 23, 2021 | GNMK | $3.2K | Sale | 166 | $19.35 | Discretionary |
| Feb 18, 2021 | GNMK | $0 | Award | 26,250 | $N/A | Discretionary |
| Jan 27, 2021 | GNMK | $1.1K | Sale | 81 | $14.06 | Discretionary |
| Dec 7, 2020 | GNMK | $3.8K | Sale | 274 | $13.97 | Discretionary |
| Nov 24, 2020 | GNMK | $4.7K | Sale | 355 | $13.17 | Discretionary |
| Oct 27, 2020 | GNMK | $771 | Sale | 68 | $11.34 | Discretionary |
| Sep 8, 2020 | GNMK | $3.1K | Sale | 285 | $11.02 | Discretionary |
| Aug 25, 2020 | GNMK | $5.4K | Sale | 379 | $14.14 | Discretionary |